STUDYING THE CHRONIC TOXICITY OF THE NEW DRUG "TIOСIN" IN PRECLINICAL PRACTICE
2023, Articles
2023

STUDYING THE CHRONIC TOXICITY OF THE NEW DRUG "TIOСIN" IN PRECLINICAL PRACTICE

Articles
Published 2023-08-01
Boboyev Behzod Muminjon ugli
Free applicant of the Department of Clinical Pharmacology of the Tashkent Medical Academy
Allayeva Munira Jurakulovna
Professor, Head of the Department of Clinical Pharmacology, Tashkent Medical Academy
pdf

How to Cite

Boboyev Behzod Muminjon ugli, & Allayeva Munira Jurakulovna. (2023). STUDYING THE CHRONIC TOXICITY OF THE NEW DRUG "TIOСIN" IN PRECLINICAL PRACTICE. Conferencea, 84–86. Retrieved from https://conferencea.org/index.php/conferences/article/view/2761
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Dyslipidemia is a violation of lipoprotein metabolism, manifested by an increase in cholesterol, triglyceride levels. Dyslipidemia is a potential risk factor for further development of cardiovascular disease.

pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Most read articles by the same author(s)